Time to Discontinuation of Tofacitinib in Rheumatoid Arthritis Patients with and Without Methotrexate: Results from a Rheumatoid Arthritis Cohort

被引：0
|
作者：
Movahedi, Mohammad [1 ]
Cesta, Angela [2 ]
Li, Xiuying [2 ]
Keystone, Edward [1 ]
Bombardier, Claire [2 ]
机构：
[1] Mt Sinai Hosp, Div Rheumatol, Toronto, ON, Canada
[2] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1428
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Time to Discontinuation of Tofacitinib and TNF Inhibitors in Rheumatoid Arthritis Patients with and Without Methotrexate: Real World Results from a Rheumatoid Arthritis Cohort
    Movahedi, Mohammad
    Cesta, Angela
    Li, Xiuying
    Keystone, Edward C.
    Bombardier, Claire
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [2] TIME TO DISCONTINUATION OF TOFACITINIB AND TNF INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS WITH AND WITHOUT METHOTREXATE: DATA FROM A RHEUMATOID ARTHRITIS COHORT
    Movahedi, M.
    Cesta, A.
    Li, X.
    Keystone, E.
    Bombardier, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 131 - 131
  • [3] Time to Discontinuation of Tofacitinib and TNF inhibitors in Rheumatoid Arthritis Patients with and without Methotrexate: Data from A Rheumatoid Arthritis Cohort
    Movahedi, Mohammad
    Cesta, Angela
    Li, Xiuying
    Keystone, Edward
    Bombardier, Claire
    [J]. JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1127 - 1127
  • [4] Time to Discontinuation of Biologic Therapy By Mechanism of Action in Rheumatoid Arthritis: Results from a Rheumatoid Arthritis Cohort
    Movahedi, Mohammad
    Hepworth, Elliot
    Mirza, Reza
    Cesta, Angela
    Larche, Maggie
    Bombardier, Claire
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [5] Discontinuation Rate of Tofacitinib Is Similar When Compared to TNF Inhibitors in Rheumatoid Arthritis Patients: Real World Results from a Rheumatoid Arthritis Cohort
    Movahedi, Mohammad
    Cesta, Angela
    Li, Xiuying
    Keystone, Edward C.
    Bombardier, Claire
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [6] Discontinuation rate of Tofacitinib is similar when compared to TNF inhibitors in rheumatoid arthritis patients: Data from a rheumatoid arthritis cohort
    Movahedi, Mohammad
    Cesta, Angela
    Li, Xiuying
    Keystone, Edward
    Bombardier, Claire
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 27 - 28
  • [7] TIME TO DISCONTINUATION OF TOFACITINAB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH AND WITHOUT METHOTREXATE: RESULTS FROM THE ONTARIO BEST PRACTICES RESEARCH INITIATIVE (OBRI) COHORT
    Movahedi, Mohammad
    Cesta, Angela
    Li Xiuying
    Bombardier, Claire
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 754 - 754
  • [8] SUBCUTANEOUS METHOTREXATE DISCONTINUATION IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Gridneva, G.
    Muraviev, Y.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1404 - 1404
  • [9] Tofacitinib versus Methotrexate in Rheumatoid Arthritis
    Lee, Eun Bong
    Fleischmann, Roy
    Hall, Stephen
    Wilkinson, Bethanie
    Bradley, John D.
    Gruben, David
    Koncz, Tamas
    Krishnaswami, Sriram
    Wallenstein, Gene V.
    Zang, Chuanbo
    Zwillich, Samuel H.
    van Vollenhoven, Ronald F.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (25): : 2377 - 2386
  • [10] Tofacitinib against methotrexate in rheumatoid arthritis
    Sanz Rubio, M.
    [J]. REVISTA CLINICA ESPANOLA, 2014, 214 (09): : 535 - 536
12345